Mortality in carotid sinus hypersensitivity: a cohort study

Joanna L Hampton1, Carol Brayne, Michelle Bradley

  • 1Department of Geriatric Medicine, Addenbrookes Hospital, Cambridge, UK.

BMJ Open
|October 25, 2011
PubMed

Insights

Carotid sinus hypersensitivity (CSH) in older adults does not increase mortality risk compared to the general population. Survival rates are similar across different CSH subtypes, confirming its neutral effect on lifespan.

Area of Science:

  • Cardiology
  • Geriatrics
  • Epidemiology

Background:

  • Carotid sinus hypersensitivity (CSH) is a prevalent condition in elderly individuals.
  • Previous research suggests a potential link between CSH and increased mortality, warranting further investigation.

Purpose of the Study:

  • To investigate the mortality rates of patients with CSH compared to a matched general population cohort.
  • To determine if different subtypes of CSH are associated with varying survival outcomes.

Main Methods:

  • A retrospective cohort study involving 1504 patients diagnosed with CSH between 1990 and 2001.
  • Comparison of mortality data with geographically and age-matched controls from the Office of National Statistics.
  • Analysis of survival curves using Kaplan-Meier methods and calculation of standardized mortality ratios (SMRs).

Main Results:

  • No significant difference in all-cause, cerebrovascular, or cardiovascular mortality was observed between CSH patients and the general population (SMRs).
  • Survival rates did not differ significantly among the three identified subtypes of CSH (p=0.2).

Conclusions:

  • CSH is not associated with an increased risk of mortality in older adults.
  • There is no evidence to suggest differential mortality risks based on CSH subtypes.
  • These findings reinforce the understanding of CSH as having a neutral effect on overall mortality.